Nitric oxide and control of pulmonary vascular resistance

Monaldi Archives for Chest Disease

Volumn 56, Issue 2, 2001, Pages 158-164

  Cremona, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Hypoxia; Pulmonary circulation; Vascular remodelling

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; ARGININE; CALCIMYCIN; CALCIUM IONOPHORE; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE; DNA; ENDOTHELIUM DERIVED RELAXING FACTOR; INDOMETACIN; INTERLEUKIN 1; METHYLENE BLUE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2;

ADRENERGIC SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DRUG EFFECT; DRUG SCREENING; HUMAN; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REGULATORY MECHANISM; TREATMENT OUTCOME; VASCULAR SURGERY; VASODILATATION;

EID: 0034888621     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (100)

1. Pulmonary hypertension. Anatomic and physiologic correlates
2. Comparative morphologic features of the pulmonary vasculature in mammals
3. The heart and pulmonary vasculature of the Ilama (Lama glama)
4. Steady-state vascular responses to graded hypoxia in isolated lungs of five species
5. Pulmonary vasomotor responses of isolated perfused cat lungs to anoxia
6. Hypoxic pulmonary vasoconstriction persists in the human transplanted lung
7. Observations on the pulmonary arterial blood pressure in the cat
8. Effect of alveolar hypoxia on pulmonary vascular resistance
9. Effect of lung inflation and hypoxia on pulmonary arterial blood volume
10. Tolbutamide reverse hypoxic pulmonary vasoconstriction in isolated rat lungs
11. Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction
12. Does normoxic pulmonary vasodilation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia?
13. Red blood cells play a crucial role in maintaining vascular reactivity to hypoxia in isolated rat lungs
14. Angiotensin is not required for hypoxic constriction is salt solution-perfused rat lungs
15. Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: Role in vascular disease
16. Acetylcholine and adenosine diphosphate cause endothelium- dependent relaxation of isolated human pulmonary arteries
17. Endothelijm-dependent relaxation of human pulmonary arteries
18. Influence of tone on responses to acetylcholine in the rabbit pulmonary vascular bed
19. Evidenc for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilation in the intact lung
20. The effect of acetylcholine on the human pulmonary circulation under normal and hypoxic conditions
21. Methylene blue selectively inhibits pulmonary vasodilator responses in cats
22. W-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin
23. Antagonists of EDRF attenuates acetylcholine induced vasodilation in isolated hamster lungs
24. A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat
25. Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat bloow perfused mesenteric arterial bed
26. Incresed vasodilator response to acetylcholine of renal blood vessels from diabetic rats
27. Endothelium-derived relaxing factor is likely to modulate the tone of resistance arteries in rabbit hindlimb in vivo
28. Control of regional blood flow by endothelium-derived nitric oxide
29. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man
30. EDRF coordinates the behaviour of vascular resistance vessels
31. Selective pulmonary vasodilation by inhaled nitrix oxide is due to hemoglobin inactivation
32. Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms
33. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue
34. W-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs
35. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo
36. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans
37. Nitrix oxide regulates basal systemic and pulmonary vascular resistance in healthy humans
38. Role of endothelium in the maintenance of low pulmonary vascular tone in normal children
39. Endothelium-dependent nonadreneric, noncholinergic neural relaxation in guinea pig pulmonary artery
40. W-nitro-L-arginine methyl ester in the cat
41. NG-monomethyl-L-arginine paradoxically relaxes preconstricted canine intrapulmonary arteries
42. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins
43. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide
44. Effects of hypoxia on endothelium-dependent relaxation to rat pulmonary artery
45. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor
46. Methylene blue potentiates vascular reactivity in isolated rat lungs
47. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats
48. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats
49. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs
50. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs
51. W-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs
52. Effects of inhibitors of nitric oxide release and action on vascular tone in isolated lungs of pig, sheep, dog and man
53. Identification of site of action of nitric oxide in isolated pig lungs by occlusion technique
54. W-nitro-L-arginine on total and segmental vascular resistances in developing lamb lungs
55. Exhaled nitric oxide in isolated pig lungs
56. Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits
57. Nature and site of action of endogenous nitric oxide in the vasculature of isolated pig lungs
58. Flow-induced release of EDRF in the pulmonary vasculature: Site of release and action
59. The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis
60. Mixed expired nitric oxide in primary pulmonary hypertension in relation to lung diffusion capacity
61. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment
62. Short-term pulmonary vasolidation with L-arginine in pulmonary hypertension
63. G-nitro-L-arginine methyl ester in conscious, Long Evans rats
64. W-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat
65. Intracardiac infusion of acetylcholine in primary pulmonary hypertension
66. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit
67. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function
68. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
69. Endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
70. Maintained endothelium-dependent pulmonary vasodilation following chronic hypoxia in the rat
71. Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats
72. EDRF suppresses an unidentified vasoconstrictor mechanisms in hypertensive rat lungs
73. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats
74. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia
75. Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling
76. Chronic EDRF inhibition and hypoxia: Effects on pulmonary circulation and systemic blood pressure
77. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease
78. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome
79. Difference between basal release of nitric oxide and response to acetylcholine in isolated lungs from patients with chronic obstructive lung disease
80. Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors not to L-arginine deficiency
81. Hemodynamic effects of basal and stimulated release of endogenous nitric oxide in isolated human lungs
82. Production of endothelium-derived relaxing factor is dependent on oxidative phosphorylation and extracellular calcium
83. Unstimulated release of endothelium derived relaxing factor is independent of mitochondrial ATP generation
84. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase
85. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
86. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension
87. Fatty acids and their prostaglandin derivatives: Inhibitors of proliferation in aortic smooth muscle cells
88. Pulmonary hypertension and increased vasoreactivity caused by repeated idomethacin in sheep
89. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension
90. Role of angiotensin-converting enzyme and angiotensin II in the development of hypoxic pulmonary hypertension
91. Importance of angiotensin-converting enzyme in pulmonary hypertension
92. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia
93. Increased gene expression for VEGF and VEGF receptors KDR/Flk and Flt in lungs exposed to acute or chronic hypoxia. Modulation of gene expression by nitric oxide
94. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
95. Continuous inahaltion of nitric oxide protects against the development of pulmonary hypertension in chronically hypoxic rats
96. Chronic inhaled nitric oxide: Effects on pulmonary vascular endothelial function and pathology in rats
97. Hypoxia induces endothelial gene expression and secretion in cultured human endothelium
98. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats
99. Endothelin-receptor antagonist bosenthan prevents and reverses hypoxic pulmonary hypertension in rats